Moreover, it will be important to improve the dual activity of curcumin derivatives or analogs, since stable concomitant inhibitors of tumor growth and P-gp activity are promising leading compounds to proceed to clinical studies in order to improve treatment of MDR cancer patients. Here, PGP is linked to neoplasm.